Canada has approved Pfizer’s COVID-19 oral antiviral treatment – CBC
OTTAWA — Canada has approved Pfizer Inc.’s COVID-19 oral antiviral treatment, the Canadian Broadcasting Corp said on Monday, citing sources, and said an announcement could be made later in the day.
Ottawa said last month that it had signed a deal with Pfizer for a million doses of the drug, pending approval by federal health regulators.
ATM
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.